Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-54P is a pseudogene that shares homology with the gene encoding the functional U7 small nuclear RNA (snRNA). While the functional U7 snRNA forms part of the U7 small nuclear ribonucleoprotein (snRNP) complex, which is essential for 3' end processing of replication-dependent histone pre-mRNAs in metazoan cells, RNU7-54P itself does not produce a functional RNA or protein product. Consequently, no biological function, disease involvement, or drug interactions are currently attributed to this pseudogene. It is not a therapeutic target and is not involved in known pathophysiological processes. This target is considered incorrect as a therapeutic or functional target due to its explicit annotation as a pseudogene, lacking coding or regulatory functionality. It should not be confused with the functional U7 snRNA, whose correct designations would be "RNA, U7 small nuclear" or "RNU7-1".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 54 pseudogene (RNU7-54P).